Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

755110

registered interest
date	20/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Secure Psychiatric Units: Ethnic Groups
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government, what data are collected regarding the number of BME patients in locked wards in England; and what plans they have to impose new requirements for the collection of such data.
tabling member printed	Lord Boateng
uin	HL1118
answer	answer is ministerial correction date of answer 31/07/2017 answer text <p>Data on the number of BME patients being treated in locked rehabilitation wards in England is not collected centrally, though we would expect trusts to pay close attention to such data.</p><p> </p><p>The Government welcomes the findings of the Care Quality Commission’s (CQC’s) report and shares its concerns about inappropriate use of locked rehabilitation wards. The department will consider the implications in discussion with NHS England, NHS Improvement and the CQC.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL1119 HL1120 question first answered 31/07/2017 13:25:20 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	147 label Biography information for Lord Boateng

755111

registered interest
date	20/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Secure Psychiatric Units: Ethnic Groups
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government how many patients from BME backgrounds spent a period of their care in locked wards in England during each of the last three years for which figures are available.
tabling member printed	Lord Boateng
uin	HL1119
answer	answer is ministerial correction date of answer 31/07/2017 answer text <p>Data on the number of BME patients being treated in locked rehabilitation wards in England is not collected centrally, though we would expect trusts to pay close attention to such data.</p><p> </p><p>The Government welcomes the findings of the Care Quality Commission’s (CQC’s) report and shares its concerns about inappropriate use of locked rehabilitation wards. The department will consider the implications in discussion with NHS England, NHS Improvement and the CQC.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL1118 HL1120 question first answered 31/07/2017 13:25:20 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	147 label Biography information for Lord Boateng

755112

registered interest
date	20/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Secure Psychiatric Units: Ethnic Groups
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government what conclusions they have drawn from the Care Quality Commission review The state of care in mental health services 2014 to 2017, published on 20 July, as to the numbers and experience of BME patients in locked wards across England.
tabling member printed	Lord Boateng
uin	HL1120
answer	answer is ministerial correction date of answer 31/07/2017 answer text <p>Data on the number of BME patients being treated in locked rehabilitation wards in England is not collected centrally, though we would expect trusts to pay close attention to such data.</p><p> </p><p>The Government welcomes the findings of the Care Quality Commission’s (CQC’s) report and shares its concerns about inappropriate use of locked rehabilitation wards. The department will consider the implications in discussion with NHS England, NHS Improvement and the CQC.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL1118 HL1119 question first answered 31/07/2017 13:25:20 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	147 label Biography information for Lord Boateng

755129

registered interest
date	20/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Blood: Contamination
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government whether the findings of the 2009 independent report by Lord Archer of Sandwell on NHS supplied contaminated blood and blood products will be taken into account by the contaminated blood inquiry announced on 11 July.
tabling member printed	Baroness Gould of Potternewton
uin	HL1137
answer	answer is ministerial correction date of answer 31/07/2017 answer text <p>The focus of the inquiry will be on establishing the truth of what happened.</p><p> </p><p>Over the summer, the Government is consulting with those affected and key stakeholder groups to discuss the scope of the inquiry.</p> answering member printed Lord O'Shaughnessy question first answered 31/07/2017 13:25:47 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	3573 label Biography information for Baroness Gould of Potternewton

753910

registered interest
date	19/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer: Mortality Rates
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government what is their assessment of the findings by Integrating the Healthcare Enterprise in its report, Comparator report on patient access to cancer medicines in Europe Revisited, that UK five-year survival outcomes for cancer lag behind the European average for nine out of ten cancers.
tabling member printed	Lord Hunt of Kings Heath
uin	HL1056
answer	answer is ministerial correction date of answer 31/07/2017 answer text <p>Cancer survival rates are at a record high and around 7,000 more people are surviving cancer after successful treatment on the National Health Service compared to three years ago. However, there is more that we can do. NHS England is leading the implementation of the recommendations of the independent Cancer Taskforce to save a further 30,000 lives by 2020.</p> answering member printed Lord O'Shaughnessy question first answered 31/07/2017 13:27:52 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

753958

registered interest
date	19/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Radioisotopes: Imports
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government (1) what assessment they have made of the potential impact of not reaching agreement with the EU by April 2019 on the supply of the radioisotope molybdenum-99 used to produce technetium-99m which is required for over 80 per cent of diagnostic medicine procedures in the UK; (2) what assessment they have made of the potential impact of delays or disruption to the supply of diagnostic medicine procedures that may result; and (3) what contingency plans they have put in place to mitigate such delays or disruption to that supply after Brexit.
tabling member printed	Lord Mendelsohn
uin	HL1104
answer	answer is ministerial correction date of answer 31/07/2017 answer text <p>The Government is fully aware of the importance of molybdenum-99 and the reliance on this medical radioisotope for diagnostic procedures in the National Health Service. The United Kingdom’s ability to import medical isotopes from Europe and the rest of the world will not be affected by withdrawal from Euratom. It is in everyone’s interest to not disrupt the timely access of treatment to patients and to ensure that cross-border trade with the European Union and Euratom is as frictionless as possible.</p> answering member printed Lord O'Shaughnessy question first answered 31/07/2017 13:38:56 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	4286 label Biography information for Lord Mendelsohn

752468

registered interest
date	17/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Parkinson's Disease: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government how much the NHS pays for a one year supply of Apomorphine for a patient with Parkinson's Disease; how much they estimate it costs to manufacture a year's supply of that drug; what assessment they have made of the difficulties of manufacturing Apomorphine to clinical standards; and whether they intend to take any steps to reduce the cost of that drug to the NHS.
tabling member printed	Lord Lucas
uin	HL914
answer	answer is ministerial correction date of answer 19/07/2017 answer text <p>The drug cost to the National Health Service for a one year supply of Apomorphine for a patient with Parkinson's Disease is estimated to be in the region of £5,300 and £9,000, based on the usual daily dose of 3 – 30mg. However, the maximum daily is 100mg, so the annual cost for some patient’s treatment may be higher.</p><p>We have no estimate of the cost of manufacture. We are not aware of any particular issues relating to the manufacture of this drug. Pharmaceutical companies participate in either the voluntary pharmaceutical price regulation scheme (PPRS) or the statutory medicines price regulation scheme, both of which regulate the cost of medicines to the NHS. Products covered by the statutory scheme are subject to a 15% cut to their list price. Companies in the PPRS pay a percentage of sales to the Government when growth in NHS spending on medicines exceeds an agreed level. NHS purchasers may also negotiate discounts with pharmaceutical companies in addition to national price regulation.</p><p> </p> answering member printed Lord O'Shaughnessy question first answered 19/07/2017 15:12:09 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1879 label Biography information for Lord Lucas

751964

registered interest
date	13/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Airports: Air Pollution
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government whether they have abandoned the Health Premium approach to funding part of the public health responsibilities of local government; and if so, why.
tabling member printed	Lord Beecham
uin	HL799
answer	answer is ministerial correction date of answer 19/07/2017 answer text <p>The Health Premium Incentive Scheme was a pilot exercise carried out in 2014/15. The Government currently has no plans to implement a similar scheme.</p> answering member printed Lord O'Shaughnessy question first answered 19/07/2017 15:06:37 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	4181 label Biography information for Lord Beecham

751974

registered interest
date	13/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	European Committee for Standardization
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government how much funding was allocated in 2016–17 to treat alcohol addiction in prisons.
tabling member printed	Lord Farmer
uin	HL809
answer	answer is ministerial correction date of answer 19/07/2017 answer text <p>The Department does not hold this information.</p> answering member printed Lord O'Shaughnessy question first answered 19/07/2017 11:03:13 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	4321 label Biography information for Lord Farmer

751979

registered interest
date	13/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Financial Services: Greater London
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government how many individuals infected with blood contaminated by hepatitis C or HIV in the 1970s and 1980s remain alive.
tabling member printed	Lord Black of Brentwood
uin	HL814
answer	answer is ministerial correction date of answer 19/07/2017 answer text <p>The Department does not hold this information.</p> answering member printed Lord O'Shaughnessy question first answered 19/07/2017 15:09:01 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	4171 label Biography information for Lord Black of Brentwood